Delivery Order SPE2DB20D2104-SPE2DB25FMSCL
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,727.33 for Trokendi XR 100 mg capsules (30-count) under a firm fixed-price contract type. This delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-set-aside award made through competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trokendi XR 100 mg capsules (30-count packages) with a ceiling value of $3,379.08. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Trokendi XR 25 mg capsules (30-count) valued at $1,476.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units) with a ceiling value of $12,939.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is set to be completed by April 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,571.94 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count units) under a firm fixed price contract. The delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,392.42. This non-set-aside award represents a competitively awarded delivery order for pharmaceutical products supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,180.32 to AmerisourceBergen Drug Corp for Trokendi XR 50 mg capsules (30-count) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price, non-set-aside delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) with a ceiling value of $2,168.86. This is a firm fixed-price delivery order with no set-aside designation, performed competitively. The order is scheduled for completion by July 16, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $1,581.56 to AmerisourceBergen Drug Corp for Trokendi XR 100 mg capsules (30-count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order, which was not set aside for small business, represents a competitively awarded pharmaceutical supply transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.96 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on August 13, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 14, 2025. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSCLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules in a 30-count package, with a contract ceiling value of $1,348.85. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a firm fixed price delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other federal healthcare systems. AmerisourceBergen's competitively awarded contracts with DLA demonstrate its capability to fulfill federal medical procurement requirements across multiple therapeutic domains, positioning it as a critical vendor for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 5/30/25 |